CCLG-produced or endorsed guidelines will be published here.
The full range of CCLG treatment guidelines, guidance and recommendations is available to CCLG members on the members area of the website.
Referral guidance for suspected cancer in children and young people
This document is a supplement to the NICE guidelines for suspected cancer: recognition and referral (NG12). The NICE guideline covers the identification of symptoms that could be caused by cancer in people of all ages. Our guidance is specific to children.
Rare endocrine tumour guidelines
Our rare endocrine tumour guidelines are intended to be a reference document for clinicians presented with the challenge of managing children and young people with rare endocrine tumour diagnoses.
Physical activity guidelines
Movement is safe, important and beneficial for every child and young person affected by cancer.
Vaccination Guideline: For Children and Young People Treated for Cancer with Standard-Dose Chemotherapy and Haemopoietic Stem Cell Transplant (HSCT)
The aim of this guideline is to draw upon the current evidence base and existing guidelines and align this with the UK national vaccine schedule and vaccine availability to recommend a pragmatic and standardised vaccination schedule for children and young…
Solid tumour biopsy guidelines
These guidelines set out recommendations for biopsy sampling of solid tumours for the purposes of diagnosis including current standard of care genetic testing, including from Q3 2020 NHS whole genome sequencing (at diagnosis), Stratified Medicine Programme in Paediatrics (SMPaeds) (at relapse) and samples destined for tissue banking with the VIVO Biobank.